Cigna Corp. rose$. 08 or. 1 percent, to $77.36. Humana Inc. fell$. 01 or percent, to $107.87. UnitedHealth Group fell$. 43 or. 6 percent, to $75.33.» Read More
Cigna Corp. rose$. 81 or 1.1 percent, to $76.45. Humana Inc. rose$. 84 or. 8 percent, to $105.58. UnitedHealth Group fell$. 24 or. 3 percent, to $75.54.
Cigna Corp. rose$. 65 or. 9 percent, to $76.29. Humana Inc. rose$. 37 or. 4 percent, to $105.11. UnitedHealth Group rose$. 36 or. 5 percent, to $76.14.
Some medical groups now want doctors to consider both the effectiveness and costs of treatment options.
Cigna Corp. fell$. 55 or. 7 percent, to $76.78. Humana Inc. fell$. 85 or. 8 percent, to $108.80. UnitedHealth Group fell $1.32 or 1.7 percent, to $78.19.
Cigna Corp. fell$. 39 or. 5 percent, to $76.94. Humana Inc. fell $1.02 or. 9 percent, to $108.63. UnitedHealth Group fell $1.57 or 2.0 percent, to $77.95.
Medicine only helps if you take it properly. Still, only about half of patients take medication as prescribed, resulting in unnecessary hospital admissions and ER visits that cost the U.S. health care system an estimated $290 billion a year. Michael A. Weber, a cardiologist at SUNY Downstate Medical Center.
Cigna Corp. fell$. 32 or. 4 percent, to $77.01. Humana Inc. fell$. 65 or. 6 percent, to $109.00. UnitedHealth Group fell$. 94 or 1.2 percent, to $78.57.
LONDON, April 16- The European Medicines Agency warned on Wednesday that vials of Roche's breast cancer drug Herceptin, thought to have been stolen from hospitals in Italy, have been tampered with and reintroduced into the supply chain. In a separate statement Roche said that counterfeit Herceptin has been discovered in Britain, Finland and Germany.
Cigna Corp. rose$. 24 or. 3 percent, to $77.35. Humana Inc. rose $1.09 or 1.0 percent, to $109.25. UnitedHealth Group rose$. 23 or. 3 percent, to $79.18.
Cigna Corp. rose$. 07 or. 1 percent, to $77.18. Humana Inc. fell$. 01 or percent, to $108.15. UnitedHealth Group rose$. 18 or. 2 percent, to $79.13.
Cigna Corp. fell$. 13 or. 2 percent, to $76.98. Humana Inc. fell$. 18 or. 2 percent, to $107.98. UnitedHealth Group fell$. 48 or. 6 percent, to $78.47.
April 14- China- focused hospital operator Chindex International Inc received a buyout offer of $23 per share, higher than the $19.50 offered by Shanghai Fosun Pharmaceutical Group and private equity firm TPG in February. Chindex, which runs the United Family Healthcare hospitals in China, did not name the new bidder.
NEW ORLEANS— The U.S. Department of Agriculture says its rural development program is lending $7.1 million to a New Orleans sausage maker and $1.3 million to a Bunkie senior care company.
March 29- Gilead Sciences Inc, under fire for pricing a new hepatitis C drug at $1,000 a pill, has discount agreements with a number of health insurers, a company executive said in an interview.
Treasury Secretary Jack Lew was running a mild fever and will stay in the hospital overnight on Tuesday after treatment for a benign enlarged prostate, a Treasury spokesperson said.
Criminal attacks on health-care providers increased dramatically—up 100 percent since 2010. And Obamacare may make it worse, according to a new study.
March 10- German health regulators have granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small U.S. biotechnology company has not yet completed its late-stage trial of the immunotherapy.
NEW YORK, March 6- Shopping for employee health insurance on private marketplaces might be the way of the future for tens of millions. However, expert opinions about growth have been based on projections, not actual consumer behavior in the exchanges that only really got going last year.
Feb 27- Pharmacy benefit manager Catamaran Corp forecast full-year profit below analysts' estimates, sending its Toronto- listed shares down as much as 12 percent. The Schaumburg, Illinois- based company said it expected adjusted earnings of $2.04- $2.19 per share for 2014, which analysts said was probably due to lower margins.
Feb 24- Pfizer Inc said on Monday that Prevnar 13, its blockbuster vaccine against childhood infections, prevented pneumonia outside of hospitals in people age 65 and older, in one of the largest drug trials ever conducted.